¼¼°èÀÇ À̼ҼҸ£ºñµå ¸ð³ë³ªÀÌÆ®·¹ÀÌÆ® Á¤Á¦ ½ÃÀå º¸°í¼­(2025³â)
Isosorbide Mononitrate Tablet Global Market Report 2025
»óǰÄÚµå : 1760582
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,222,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 8,993,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,765,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

À̼ҼҸ£ºñµå ¸ð³ë³ªÀÌÆ®·¹ÀÌÆ® Á¤Á¦ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀåÀÌ Àü¸ÁµÉ ¿¹Á¤ÀÔ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ¼ºÀåÀº ±ÔÁ¦ ½ÂÀÎ ¹× ƯÇã ¸¸·á, Á¦³×¸¯ ÀǾàǰÀÇ Ã¤Åà Áõ°¡, ¶óÀÌÇÁ½ºÅ¸ÀÏ °ü·Ã À§Çè ¿ä¼ÒÀÇ Áõ°¡, ½ÉÇ÷°ü Áúȯ °ü¸®¸¦ À§ÇÑ Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê, Áø´Ü ÀÎÇÁ¶ó °³¼±, ÀÎ½Ä Ä·ÆäÀο¡ ±âÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ±â°£ÀÇ ÁÖ¿ä µ¿Çâ¿¡´Â ¼­¹æÇü Á¦Á¦ÀÇ Áøº¸, ±â¼ú Çõ½Å, µðÁöÅÐ Çコ Ç÷§Æû°ú E-CommerceÀÇ ´ëµÎ, µðÁöÅÐ Çコ ±â¼úÀÇ ÅëÇÕ, À̼ҼҸ£ºñµå ¸ð³ë³ªÀÌÆ®·¹ÀÌÆ®¿Í ´Ù¸¥ ½ÉÇ÷°ü Ä¡·áÁ¦°úÀÇ º´¿ë µîÀÌ ÀÖ½À´Ï´Ù.

½ÉÇ÷°üÁúȯ(CVD)ÀÇ À¯º´·ü Áõ°¡°¡ À̼ҼҸ£ºñµå ¸ð³ë³ªÀÌÆ®·¹ÀÌÆ® Á¤Á¦ ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¾î¶² ¿äÀÎÀ¸·Î ¸¸¿¬Çϰí ÀÖ¾î ºñ¸¸, °íÇ÷¾Ð, °íÄÝ·¹½ºÅ×·Ñ µîÀÇ Áõ»óÀÇ ÀÏÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·Î ÀÎÇØ ÀÌ·¯ÇÑ Áúº´À» °ü¸®ÇÏ´Â µ¥ ÀϹÝÀûÀ¸·Î »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. 2021³â »ç¸ÁÀÚ ¼ö´Â 1¸¸ 4,100¸í, 2022³â¿¡´Â 1¸¸ 4,900¸íÀ¸·Î Áõ°¡Çß½À´Ï´Ù.

¿Â¶óÀÎ ¾à±¹ÀÇ º¸±ÞÀÌ, À̼ҼҸ£ºñµå ¸ð³ë³ªÀÌÆ®·¹ÀÌÆ® Á¤Á¦ ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í ¹Ð¾îÁÖ°í ÀÖ½À´Ï´Ù. Pharmacies(ASOP)°¡ 2023³â 9¿ù¿¡ ½Ç½ÃÇÑ Á¶»ç¿¡ ÀÇÇϸé, 18¼¼ ÀÌ»óÀÇ ¹Ì±¹ÀÎÀÇ 52%°¡ ¿Â¶óÀÎ ¾à±¹À» ÀÌ¿ëÇÑ ÀûÀÌ ÀÖ¾î, ÀÌÀüº¸´Ù ÇöÀúÇÏ°Ô Áõ°¡Çϰí ÀÖ´Â °ÍÀÌ ¹àÇôÁ³½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀåÀÇ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ª ÀüÀï ¹× °ü¼¼, Äڷγª ¹× ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔ

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå : °æÀï º¥Ä¡¸¶Å· ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ±â¾÷ ÇÕº´ ¹× Àμö(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡ ¹× ºÎ¹®°ú Àü·«

Á¦36Àå ºÎ·Ï

SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Isosorbide mononitrate tablets are long-acting nitrate medications primarily used to prevent and control chest pain (angina) associated with coronary artery disease. The medication works by relaxing and dilating blood vessels, particularly in the heart, which allows for increased blood and oxygen flow while reducing the heart's workload. Unlike fast-acting nitrates used for immediate relief, isosorbide mononitrate is taken regularly as a maintenance therapy to reduce the frequency and severity of angina attacks and improve overall cardiovascular function.

The main dosage forms of isosorbide mononitrate tablets are immediate-release tablets and extended-release tablets. Immediate-release tablets are designed to dissolve quickly, allowing for rapid absorption and fast relief, especially for conditions such as angina. These tablets are used for various indications, including angina pectoris, heart failure, and hypertension, and are distributed through channels such as hospital pharmacies, retail pharmacies, and online pharmacies.

The isosorbide mononitrate tablet market research report is one of a series of new reports from The Business Research Company that provides isosorbide mononitrate tablet market statistics, including the isosorbide mononitrate tablet industry global market size, regional shares, competitors with the isosorbide mononitrate tablet market share, detailed isosorbide mononitrate tablet market segments, market trends, and opportunities, and any further data you may need to thrive in the isosorbide mononitrate tablet industry. This isosorbide mononitrate tablet market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The isosorbide mononitrate tablet market size has grown strongly in recent years. It will grow from$1.14 billion in 2024 to $1.21 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth during the historic period can be attributed to the growing elderly population, the increasing incidence of heart-related conditions, greater awareness of heart health, the availability of generic drugs, and public health campaigns.

The isosorbide mononitrate tablet market size is expected to see strong growth in the next few years. It will grow to$1.51 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to regulatory approvals and patent expirations, the increasing adoption of generic drugs, growth in lifestyle-related risk factors, government initiatives for cardiovascular disease management, improvements in diagnostic infrastructure, and awareness campaigns. Key trends during this period include advancements in extended-release formulations, technological innovations, the rise of digital health platforms and e-commerce, integration of digital health technologies, and the combination of isosorbide mononitrate with other cardiovascular drugs.

The increasing prevalence of cardiovascular diseases (CVDs) is driving the growth of the isosorbide mononitrate tablet market. CVDs, including coronary artery disease, heart failure, and hypertension, are becoming more widespread due to factors such as unhealthy diets high in saturated fats, trans fats, sodium, and added sugars, which contribute to conditions such as obesity, hypertension, and high cholesterol. Isosorbide mononitrate tablets are commonly used to manage these diseases by relaxing and widening blood vessels, which improves blood flow, reduces the heart's workload, and alleviates chest pain (angina). According to a report from the Australian Institute of Health and Welfare in December 2023, coronary heart disease (CHD) deaths in Australia have been increasing, with 14,100 deaths in 2021 rising to 14,900 in 2022. This growing prevalence of cardiovascular diseases is significantly contributing to the demand for effective treatments, such as isosorbide mononitrate tablets.

The increasing adoption of online pharmacies is further propelling the growth of the isosorbide mononitrate tablet market. Consumers are seeking greater convenience, affordability, and accessibility to medications without the need to visit physical pharmacies. Online pharmacies offer home delivery, competitive pricing, and improved availability, particularly for patients managing chronic conditions such as cardiovascular diseases. A survey conducted by the Alliance for Safe Online Pharmacies (ASOP) in September 2023 revealed that 52% of Americans aged 18 and older had used an online pharmacy, showing a notable increase from previous years. This surge in online pharmacy usage is making it easier for patients to access essential medications, including isosorbide mononitrate tablets, fueling market growth.

Pharmaceutical companies are focusing on the development of extended-release (ER) formulations of isosorbide mononitrate to improve patient compliance and enhance treatment outcomes. ER tablets provide sustained therapeutic effects by gradually releasing the medication over an extended period, reducing the need for frequent dosing and ensuring consistent blood levels of the drug. In February 2024, Zydus Lifesciences Limited received approval from the U.S. Food and Drug Administration (FDA) to market isosorbide mononitrate extended-release tablets in strengths of 30 mg, 60 mg, and 120 mg. These tablets help prevent chest pain (angina) in patients with coronary artery disease and offer a more convenient treatment option for those requiring long-term management, further contributing to the growth of the isosorbide mononitrate tablet market.

Major players in the isosorbide mononitrate tablet market are Pfizer Inc., Merck & Co. Inc., AstraZeneca PLC, Abbott Laboratories Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Zydus Lifesciences Limited, Recipeharm, Torrent Pharmaceuticals Ltd., Micro Labs Ltd., Lotus Pharmaceuticals, Healthy Inc., Qilu Pharmaceutical Co. Ltd, Lunan Pharmaceutical Group, Johnlee Pharmaceuticals Pvt. Ltd., Niksan Pharmaceutical, Shandong Keyuan Pharmaceutical, and Prevego Healthcare & Research Private Limited.

North America was the largest region in the isosorbide mononitrate tablet market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in isosorbide mononitrate tablet report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the isosorbide mononitrate tablet market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The isosorbide mononitrate tablet market consists of sales of dilatrate-SR, isochron, monoket, and imdur, pediatric and geriatric-adjusted tablets, and combination products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Isosorbide Mononitrate Tablet Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on isosorbide mononitrate tablet market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for isosorbide mononitrate tablet ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The isosorbide mononitrate tablet market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Isosorbide Mononitrate Tablet Market Characteristics

3. Isosorbide Mononitrate Tablet Market Trends And Strategies

4. Isosorbide Mononitrate Tablet Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Isosorbide Mononitrate Tablet Growth Analysis And Strategic Analysis Framework

6. Isosorbide Mononitrate Tablet Market Segmentation

7. Isosorbide Mononitrate Tablet Market Regional And Country Analysis

8. Asia-Pacific Isosorbide Mononitrate Tablet Market

9. China Isosorbide Mononitrate Tablet Market

10. India Isosorbide Mononitrate Tablet Market

11. Japan Isosorbide Mononitrate Tablet Market

12. Australia Isosorbide Mononitrate Tablet Market

13. Indonesia Isosorbide Mononitrate Tablet Market

14. South Korea Isosorbide Mononitrate Tablet Market

15. Western Europe Isosorbide Mononitrate Tablet Market

16. UK Isosorbide Mononitrate Tablet Market

17. Germany Isosorbide Mononitrate Tablet Market

18. France Isosorbide Mononitrate Tablet Market

19. Italy Isosorbide Mononitrate Tablet Market

20. Spain Isosorbide Mononitrate Tablet Market

21. Eastern Europe Isosorbide Mononitrate Tablet Market

22. Russia Isosorbide Mononitrate Tablet Market

23. North America Isosorbide Mononitrate Tablet Market

24. USA Isosorbide Mononitrate Tablet Market

25. Canada Isosorbide Mononitrate Tablet Market

26. South America Isosorbide Mononitrate Tablet Market

27. Brazil Isosorbide Mononitrate Tablet Market

28. Middle East Isosorbide Mononitrate Tablet Market

29. Africa Isosorbide Mononitrate Tablet Market

30. Isosorbide Mononitrate Tablet Market Competitive Landscape And Company Profiles

31. Isosorbide Mononitrate Tablet Market Other Major And Innovative Companies

32. Global Isosorbide Mononitrate Tablet Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Isosorbide Mononitrate Tablet Market

34. Recent Developments In The Isosorbide Mononitrate Tablet Market

35. Isosorbide Mononitrate Tablet Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â